Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)
ENROLLING_BY_INVITATION
Status
Conditions
- Diabetes Mellitus, Type 2
- Liver Fibrosis
- Liver Steatoses
- Hepatic Steatosis
- Hepatic Fibrosis
- Overweight or Obesity
- MASLD
- MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
- Cardio-metabolic Risk
- Cardio-metabolic Health
- Hypertension
- Dyslipidaemia
Interventions
- OTHER: early time restricted Mediterranean diet
- DRUG: Mysimba
Sponsor
Carmen Dietvorst